Breast Surgery — MCQs
On this page
Which of the following is NOT a predisposing factor for breast cancer?
A 50-year-old woman has a lumpectomy following mammographic discovery of a carcinoma of the breast. Which of the following is a well-known characteristic or association of breast cancer?
A 50-year-old patient has recently undergone a mastectomy for a 2.5 cm multicentric breast cancer with three positive axillary lymph nodes (stage IIB). A metastatic survey is done, and is negative, and she receives adjuvant chemotherapy. What is the most common site for distant metastasis in this patient?
Incisional biopsy of a breast mass in a 35-year-old woman demonstrates a hypercellular fibroadenoma (Cystosarcoma phyllodes) at the time of frozen section. Appropriate management of this lesion could include?
The type of ductal carcinoma in situ (DCIS) most likely to result in a palpable abnormality in the breast is:
Green discharge from the nipple is most commonly seen with which of the following conditions?
In Patey's mastectomy, which of the following steps is NOT performed?
A 53-year-old woman discovers a lump in her breast. Physical examination confirms a mass in the lower, outer quadrant of the left breast. Mammography demonstrates an ill-defined, stellate density measuring 1 cm. Needle aspiration reveals malignant ductal epithelial cells. A modified radical mastectomy is performed. The surgical specimen reveals a firm irregular mass. Which of the following cellular markers would be the most useful to evaluate before considering therapeutic options for this patient?
Paget's disease of the breast is indicative of which type of carcinoma?
Which of the following statements about phyllodes tumor is false?
Breast Surgery Indian Medical PG Practice Questions and MCQs
Question 251: Which of the following is NOT a predisposing factor for breast cancer?
- A. Abscess (Correct Answer)
- B. Positive family history
- C. Nulliparity
- D. High socio-economic status
Explanation: **Explanation:** The correct answer is **Abscess**. Breast abscess is an acute inflammatory condition, usually associated with lactation (*Staphylococcus aureus*), and is **not** a predisposing factor for malignancy. While chronic inflammation in some organs can lead to cancer, there is no established causal link between breast abscesses and the development of breast carcinoma. **Analysis of Options:** * **Positive Family History:** This is a significant risk factor. Approximately 5-10% of breast cancers are hereditary, often involving mutations in **BRCA1 and BRCA2** genes. A first-degree relative with breast cancer doubles the risk. * **Nulliparity:** Breast cancer risk is heavily influenced by cumulative lifetime exposure to estrogen. Nulliparity (never having given birth) or a late age at first full-term pregnancy (>30 years) increases risk because the breast tissue undergoes fewer periods of hormonal "rest" provided by pregnancy and lactation. * **High Socio-economic Status:** This is a well-documented epidemiological risk factor. It is often a surrogate for lifestyle factors such as delayed childbearing, lower parity, use of oral contraceptives, and dietary habits (higher fat intake/obesity). **High-Yield Clinical Pearls for NEET-PG:** * **Early menarche (<12 years)** and **late menopause (>55 years)** are significant risk factors due to prolonged estrogen exposure. * **Atypical Ductal Hyperplasia (ADH)** and **Atypical Lobular Hyperplasia (ALH)** carry a 4-5x increased risk of cancer. * **Gail Model** is the most commonly used tool for assessing the cumulative risk of developing breast cancer. * **Protective factors:** Early pregnancy, breastfeeding, and regular physical activity.
Question 252: A 50-year-old woman has a lumpectomy following mammographic discovery of a carcinoma of the breast. Which of the following is a well-known characteristic or association of breast cancer?
- A. Low-fat diet
- B. Positive family history (Correct Answer)
- C. Excessive thinness
- D. Multiparity
Explanation: **Explanation:** **1. Why Positive Family History is Correct:** Family history is one of the most significant non-modifiable risk factors for breast cancer. Approximately 5–10% of breast cancers are hereditary, often linked to mutations in the **BRCA1 and BRCA2** genes. A woman with a first-degree relative (mother, sister, or daughter) diagnosed with breast cancer has roughly **double the risk** compared to the general population. The risk increases further if the relative was diagnosed pre-menopausally or if multiple relatives are affected. **2. Analysis of Incorrect Options:** * **A. Low-fat diet:** High dietary fat intake is traditionally associated with an increased risk of breast cancer (though data is mixed), whereas a low-fat diet is considered a protective or neutral factor. * **C. Excessive thinness:** In post-menopausal women (like the 50-year-old in this case), **obesity** is a major risk factor. Adipose tissue is the primary source of estrogen (via peripheral aromatization of androgens) after menopause; therefore, thinness is actually protective. * **D. Multiparity:** High parity (having many children) is a **protective factor**. Increased risk is associated with **nulliparity** or having the first full-term pregnancy after the age of 30, as these conditions increase the total lifetime exposure to cyclical estrogen. **3. NEET-PG High-Yield Pearls:** * **Most common site:** Upper Outer Quadrant (Tail of Spence). * **Risk Factors (The "Estrogen Window"):** Early menarche (<12 years), late menopause (>55 years), and HRT increase risk due to prolonged estrogen exposure. * **BRCA Mutations:** BRCA1 (Chromosome 17) and BRCA2 (Chromosome 13). BRCA1 is more strongly associated with Triple Negative Breast Cancer (TNBC). * **Li-Fraumeni Syndrome:** Associated with p53 mutation; increases risk of breast cancer, sarcomas, and leukemia.
Question 253: A 50-year-old patient has recently undergone a mastectomy for a 2.5 cm multicentric breast cancer with three positive axillary lymph nodes (stage IIB). A metastatic survey is done, and is negative, and she receives adjuvant chemotherapy. What is the most common site for distant metastasis in this patient?
- A. Brain
- B. Bone (Correct Answer)
- C. Lung
- D. Gastrointestinal tract
Explanation: ### Explanation **Correct Option: B. Bone** In breast cancer, the most common site for distant (systemic) metastasis is the **bone**. This holds true across most molecular subtypes and stages. Approximately 70% of patients with advanced breast cancer will develop bone metastases. The mechanism involves the "seed and soil" hypothesis, where breast cancer cells have a high affinity for the bone marrow microenvironment. Bone metastases in breast cancer are typically **osteolytic**, though they can be mixed or osteoblastic (especially in certain subtypes). **Analysis of Incorrect Options:** * **A. Brain:** While breast cancer is a common cause of brain metastasis, it is significantly less frequent than bone, lung, or liver. Brain involvement is more commonly seen in HER2-positive and Triple-Negative Breast Cancer (TNBC) subtypes, usually occurring later in the disease course. * **C. Lung:** The lung is the second most common site for distant metastasis and is often the first site of metastasis in patients with TNBC. However, statistically, bone involvement remains more prevalent overall. * **D. Gastrointestinal tract:** Metastasis to the GI tract is rare. Interestingly, **Invasive Lobular Carcinoma (ILC)** has a unique predilection for spreading to the GI tract, peritoneum, and ovaries, but it is still less common than bone spread. **Clinical Pearls for NEET-PG:** * **Most common site of distant metastasis:** Bone. * **Most common visceral organ for metastasis:** Lung (followed by the liver). * **Most common site for Lobular Carcinoma:** Atypical sites like the GI tract, peritoneum, and retroperitoneum. * **Batson’s Plexus:** The valveless vertebral venous plexus explains why breast cancer frequently spreads to the axial skeleton (spine and pelvis) without passing through the lungs first. * **Bone Scan (Technetium-99m):** The most sensitive screening tool for detecting asymptomatic bone metastases.
Question 254: Incisional biopsy of a breast mass in a 35-year-old woman demonstrates a hypercellular fibroadenoma (Cystosarcoma phyllodes) at the time of frozen section. Appropriate management of this lesion could include?
- A. Wide local excision with a rim of normal tissue (Correct Answer)
- B. Lumpectomy and axillary lymphadenectomy
- C. Modified radical mastectomy
- D. Excision and postoperative radiotherapy
Explanation: **Explanation:** Phyllodes tumor (Cystosarcoma phyllodes) is a fibroepithelial neoplasm that resembles a fibroadenoma but is characterized by a "leaf-like" growth pattern and high stromal cellularity. The management of these tumors depends on their biological behavior, which ranges from benign to malignant. **Why Option A is correct:** The standard of care for Phyllodes tumor, regardless of whether it is benign, borderline, or malignant, is **Wide Local Excision (WLE)** with a surgical margin of at least **1 cm**. This is because these tumors have a high propensity for local recurrence if the margins are involved. Unlike breast cancer, Phyllodes tumors are not truly invasive in a way that requires systemic clearance; they are locally aggressive. **Why other options are incorrect:** * **Option B:** Axillary lymphadenectomy is unnecessary because Phyllodes tumors are mesenchymal in origin and spread primarily via the **hematogenous route**, not the lymphatic system. Lymph node involvement is seen in less than 1% of cases. * **Option C:** Modified Radical Mastectomy (MRM) is overtreatment. Simple mastectomy is only indicated if the tumor is so large that a 1 cm margin cannot be achieved with breast-conserving surgery or for recurrent disease. * **Option D:** Radiotherapy is not the primary treatment. It may be considered for high-risk malignant Phyllodes or recurrent cases, but the definitive initial management is surgical excision. **NEET-PG High-Yield Pearls:** * **Age:** Typically occurs in women aged 35–50 (older than the typical fibroadenoma age). * **Clinical Feature:** Rapidly enlarging, painless, firm, mobile mass. * **Pathology:** Characterized by "leaf-like" stromal projections and increased stromal cellularity. * **Metastasis:** Most common site of distant metastasis is the **Lungs**. * **Treatment Summary:** WLE (1 cm margin) is the gold standard. No axillary dissection is needed.
Question 255: The type of ductal carcinoma in situ (DCIS) most likely to result in a palpable abnormality in the breast is:
- A. Apocrine DCIS
- B. Neuroendocrine DCIS
- C. Well differentiated DCIS
- D. Comedo DCIS (Correct Answer)
Explanation: **Explanation:** **Comedo DCIS** is the most aggressive subtype of Ductal Carcinoma in Situ. It is characterized by high-grade malignant cells with significant pleomorphism and central **extensive necrosis**. This necrotic debris often undergoes **dystrophic calcification**, which can be seen on mammography as linear or branching "crushed stone" calcifications. The combination of dense cellular proliferation, surrounding periductal inflammation, and fibrosis makes this subtype more likely to form a firm, **palpable mass** compared to non-comedo types, which are typically clinically occult. **Analysis of Incorrect Options:** * **Apocrine DCIS:** This is a rare variant where cells show apocrine differentiation (granular eosinophilic cytoplasm). While it can be high-grade, it does not typically present with the massive central necrosis and associated stromal reaction characteristic of the comedo type. * **Neuroendocrine DCIS:** This subtype shows expression of neuroendocrine markers (e.g., chromogranin). It is usually an incidental finding and lacks the aggressive growth pattern required to form a palpable abnormality. * **Well-differentiated (Low-grade) DCIS:** These lesions (e.g., cribriform or papillary patterns) grow slowly and lack significant necrosis. They are almost always non-palpable and are usually detected only via screening mammography as fine, stippled calcifications. **NEET-PG High-Yield Pearls:** * **DCIS** is a precursor to invasive ductal carcinoma; **Comedo** is the subtype with the highest risk of progression to invasion. * **Van Nuys Prognostic Index:** Used to predict the risk of local recurrence in DCIS (factors include size, margin width, and pathologic classification/grade). * **Treatment:** Usually involves wide local excision with or without radiotherapy. Mastectomy is reserved for multicentric disease or large tumors relative to breast size.
Question 256: Green discharge from the nipple is most commonly seen with which of the following conditions?
- A. Duct papilloma
- B. Duct ectasia (Correct Answer)
- C. Retention cyst
- D. Fibroadenosis
Explanation: **Explanation:** **Duct ectasia** is the most common cause of **greenish or brownish (multicolored) nipple discharge**. This condition involves the dilation of the major subareolar ducts, which become filled with lipid-rich debris and stagnant secretions. As these secretions decompose and thicken, they take on a characteristic "cheesy" or "toothpaste-like" consistency and a dark green or blackish hue. It is typically seen in perimenopausal women and is often associated with smoking. **Analysis of Incorrect Options:** * **Duct Papilloma:** This is the most common cause of **bloody (serosanguinous)** nipple discharge. It is usually a solitary, small growth within a major duct. * **Retention Cyst:** These are typically associated with lactation (e.g., Galactocele) and present with **milky** discharge or a localized lump rather than green discharge. * **Fibroadenosis (Fibrocystic changes):** While it can cause nipple discharge, it is more commonly **serous (straw-colored)** or greenish-yellow, but it is primarily characterized by cyclical mastalgia and "lumpy" breasts. Duct ectasia remains the more classic and frequent association for dark green discharge. **Clinical Pearls for NEET-PG:** * **Bloody discharge:** Think Intraductal Papilloma (most common) or Duct Carcinoma. * **Milky discharge (non-lactational):** Think Hyperprolactinemia (Pituitary adenoma) or drugs. * **Serous discharge:** Think Fibrocystic disease or early pregnancy. * **Management of Duct Ectasia:** If symptomatic or suspicious, the surgical procedure of choice is **Hadfield’s operation** (Total duct excision).
Question 257: In Patey's mastectomy, which of the following steps is NOT performed?
- A. Nipple and areola are removed.
- B. Surrounding normal tissue of the tumor is removed.
- C. Pectoralis major muscle is removed. (Correct Answer)
- D. Pectoralis minor muscle is removed.
Explanation: **Explanation:** The core concept in breast surgery for NEET-PG is distinguishing between the various types of mastectomies based on which structures are preserved. **1. Why Option C is the correct answer:** In **Patey’s Modified Radical Mastectomy (MRM)**, the **Pectoralis major muscle is preserved**. The defining feature of Patey’s technique is the **removal of the Pectoralis minor muscle** (or its retraction) to facilitate complete clearance of Level III axillary lymph nodes. Removing the Pectoralis major was a feature of the Halsted Radical Mastectomy, which is now obsolete due to significant morbidity and lack of survival benefit over MRM. **2. Analysis of Incorrect Options:** * **Option A (Nipple and areola):** In any form of Modified Radical Mastectomy (including Patey’s), the Nipple-Areola Complex (NAC) is removed along with the elliptical skin incision to ensure oncological safety. * **Option B (Surrounding normal tissue):** The procedure involves removing the entire breast disc (parenchyma) along with the tumor and a margin of normal tissue to ensure clear margins. * **Option D (Pectoralis minor):** This is a standard step in Patey’s version of MRM. By removing the Pectoralis minor, the surgeon gains access to the highest axillary nodes (Level III/Apical nodes). **Clinical Pearls for NEET-PG:** * **Auchincloss MRM:** Both Pectoralis major and minor are **preserved**. (Most common MRM today). * **Patey’s MRM:** Pectoralis major is preserved; Pectoralis minor is **removed**. * **Halsted Radical Mastectomy:** Both Pectoralis major and minor are **removed**. * **Scanlon’s MRM:** Pectoralis major is preserved; Pectoralis minor is **transected and repaired** (to access Level III nodes). * **Nerves at risk:** Long thoracic nerve (Serratus anterior - Winging of scapula) and Thoracodorsal nerve (Latissimus dorsi).
Question 258: A 53-year-old woman discovers a lump in her breast. Physical examination confirms a mass in the lower, outer quadrant of the left breast. Mammography demonstrates an ill-defined, stellate density measuring 1 cm. Needle aspiration reveals malignant ductal epithelial cells. A modified radical mastectomy is performed. The surgical specimen reveals a firm irregular mass. Which of the following cellular markers would be the most useful to evaluate before considering therapeutic options for this patient?
- A. Collagenase
- B. Estrogen receptors (Correct Answer)
- C. Galactosyltransferase
- D. Lysosomal acid hydrolases
Explanation: ### Explanation The patient presents with a classic case of **Infiltrating Ductal Carcinoma (IDC)** of the breast, confirmed by physical exam (stellate mass), mammography, and cytology. In modern breast cancer management, the determination of **hormone receptor status** is the most critical step following diagnosis to guide systemic therapy. **Why Estrogen Receptors (ER) are the Correct Choice:** * **Therapeutic Guidance:** ER and Progesterone Receptor (PR) status are primary predictors of response to endocrine therapy. Patients who are ER-positive benefit significantly from drugs like **Tamoxifen** (Selective Estrogen Receptor Modulator) or **Aromatase Inhibitors** (e.g., Anastrozole). * **Prognostic Value:** Generally, ER-positive tumors are well-differentiated and have a more favorable prognosis compared to ER-negative tumors. * **Standard of Care:** Along with HER2/neu status, ER/PR testing is mandatory for every newly diagnosed breast cancer to categorize the molecular subtype (e.g., Luminal A vs. B). **Analysis of Incorrect Options:** * **A. Collagenase:** While enzymes like Matrix Metalloproteinases (MMPs) help in tumor invasion by degrading the extracellular matrix, they have no established role in clinical decision-making or targeted therapy. * **C. Galactosyltransferase:** This is an enzyme involved in lactose synthesis and carbohydrate chain elongation. It is not a biomarker for breast cancer prognosis or treatment. * **D. Lysosomal acid hydrolases:** These are enzymes found in lysosomes responsible for intracellular digestion. While they may be elevated in necrotic areas of a tumor, they lack specificity and therapeutic utility. **NEET-PG High-Yield Pearls:** * **Most common site of breast cancer:** Upper Outer Quadrant (UOQ). * **Most common histological type:** Infiltrating Ductal Carcinoma (NOS). * **Sentinel Lymph Node Biopsy (SLNB):** The gold standard for axillary staging in clinically node-negative (cN0) patients. * **Triple Negative Breast Cancer (TNBC):** Defined as ER-ve, PR-ve, and HER2-ve; it carries the worst prognosis and is often associated with BRCA1 mutations.
Question 259: Paget's disease of the breast is indicative of which type of carcinoma?
- A. Ductal carcinoma (Correct Answer)
- B. Lobular carcinoma
- C. Papillary carcinoma
- D. Medullary carcinoma
Explanation: **Explanation:** Paget’s disease of the breast is a clinical condition characterized by an eczematous, crusting lesion of the nipple-areola complex. It is almost always (95-100% of cases) associated with an underlying **Ductal Carcinoma**, which can be either *Ductal Carcinoma in Situ (DCIS)* or *Invasive Ductal Carcinoma (IDC)*. The underlying medical concept is the **Epidermotropic Theory**: Malignant cells (Paget cells) migrate from the underlying lactiferous ducts into the epidermis of the nipple. These Paget cells are large, pale-staining cells with prominent nucleoli, typically found within the basement membrane. **Why other options are incorrect:** * **Lobular Carcinoma:** While Invasive Lobular Carcinoma is the second most common breast cancer, it typically presents as a diffuse thickening or mass and is not associated with the migration of cells to the nipple epidermis. * **Papillary & Medullary Carcinoma:** These are specific subtypes of invasive ductal carcinoma. While they are ductal in origin, Paget’s disease is a generalized marker for ductal malignancy (most commonly DCIS or IDC-NOS) rather than these specific, rarer variants. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Often mistaken for nipple eczema. **Rule:** Any "eczema" of the nipple that does not respond to topical steroids must be biopsied. * **Diagnosis:** Confirmed by **Punch Biopsy** of the nipple. * **Pathology:** Paget cells are **PAS positive** (diastase resistant) and stain positive for **Her2/neu** protein. * **Management:** If no mass is palpable, the prognosis is excellent; if a mass is palpable, it usually indicates invasive disease and follows the standard protocol for IDC.
Question 260: Which of the following statements about phyllodes tumor is false?
- A. Always malignant (Correct Answer)
- B. Grows rapidly
- C. Unilateral
- D. Excision is the treatment
Explanation: **Explanation:** Phyllodes tumor (Cystosarcoma Phyllodes) is a fibroepithelial tumor of the breast characterized by a "leaf-like" appearance on histology. **1. Why Option A is False (The Correct Answer):** Phyllodes tumors are **not always malignant**. They are classified by the WHO into three categories based on histological features (stromal cellularity, atypia, mitotic rate, and border infiltration): * **Benign (60-75%):** The most common type. * **Borderline:** Intermediate features. * **Malignant (approx. 10-20%):** Capable of hematogenous metastasis (most commonly to the lungs). **2. Why the other options are True:** * **Option B (Grows rapidly):** These tumors are known for their characteristic rapid increase in size, often presenting as a large, painless, mobile mass that can cause pressure necrosis of the overlying skin. * **Option C (Unilateral):** They are almost always unilateral and solitary. Bilateral involvement is extremely rare. * **Option D (Excision is the treatment):** The standard treatment is **Wide Local Excision** with at least a **1 cm margin**. Simple mastectomy is reserved only for very large tumors where a 1 cm margin cannot be achieved with breast conservation. Axillary lymph node dissection is generally not required as these tumors spread hematogenously, not via lymphatics. **High-Yield Clinical Pearls for NEET-PG:** * **Age:** Typically occurs in women aged 40–50 (older than the typical fibroadenoma age group). * **Histology:** Characterized by increased stromal cellularity compared to fibroadenoma. * **Imaging:** Hard to distinguish from fibroadenoma on USG/Mammography; diagnosis often requires Core Needle Biopsy. * **Recurrence:** They have a high tendency for local recurrence if margins are inadequate.
Practice by Chapter
Breast Anatomy and Physiology
Practice Questions
Benign Breast Diseases
Practice Questions
Breast Cancer Screening
Practice Questions
Breast Cancer: Diagnosis and Staging
Practice Questions
Surgical Management of Breast Cancer
Practice Questions
Oncoplastic Breast Surgery
Practice Questions
Sentinel Lymph Node Biopsy
Practice Questions
Axillary Surgery
Practice Questions
Breast Reconstruction Techniques
Practice Questions
Male Breast Disorders
Practice Questions
Phyllodes Tumors
Practice Questions
Management of Ductal Carcinoma In Situ
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free